Anzeige
Mehr »
Donnerstag, 16.10.2025 - Börsentäglich über 12.000 News
Milliardär-gestützt: Eine 10-Bagger-Goldaktie, die gerade erst durchstartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
255 Leser
Artikel bewerten:
(1)

Nationwide Survey Reveals Brits' Top Ten Sources of Stress Throughout the Pandemic and they're NOT what the experts predicted

LONDON, April 7, 2021 /PRNewswire/ -- Brits have been reflecting on their emotional journey over the last year and a YouGov survey of 3000 across the UK has revealed some surprising results about what has caused them the most stress during the past year.

No.1 cause of stress was revealed to be worries about the wellbeing of loved ones, suggesting we're a more compassionate nation as a result of the pandemic. Other stressors included working from home, household chores and home-schooling. In a surprising finding and dominating four out of the top five, were all issues related to weight gain.

Top Ten Causes of Stress During the Pandemic

  1. Worrying about the health of a loved one (51%)
  2. Putting on weight (35%)
  3. Worrying about my own health (32%)
  4. Not being able to get much exercise (32%)
  5. Worrying about being overweight (27%)
  6. Working from home (23%)
  7. Doing household chores (18%)
  8. Not being able to work (14%)
  9. Taking care of parents/relatives (14%)
  10. Home-schooling (13%)

The survey, commissioned by weight loss pioneers Allurion, showed that 50% of Britons said they had gained weight during the pandemic and that concerns about their body are now the aspect of their life that they are least satisfied with. 35% said their weight had caused them stress, and 44% said they're unhappy about the current condition of their body.

Psychologist Honey Langcaster-James, "It's heartening to see that our primary concern throughout the pandemic has remained the wellbeing of our loved ones, however, it seems that our concern for others may have come at a cost to looking after ourselves. We've been neglecting our own health-related needs and eating for emotional reasons, so now people are anxious about the weight they've put on during the pandemic."

According to Allurion, feelings of 'hunger' is the number one problem people face when trying to control their weight. 75% of all those who gained weight in the survey stating they would be able to change their approach to eating if only they felt full.

To help people who struggle to lose weight and offering a non-surgical option, Allurion launched Elipse Weight Loss Balloon and Weight Loss Program. Elipse Balloon is a pill which is swallowed by a patient under a doctor's supervision; once inside the stomach, it expands in the stomach to around the size of a grapefruit and allows patients to lose 10 to 15% of their body weight in around 16 weeks. It doesn't require surgery, endoscopy, or anaesthesia*. This means that someone weighing around 15st could potentially lose more than 2st in around 4 months.

Allurion's Program combines its high-tech balloon solution with a full package of support to help its patients develop good lifestyle habits that can remain with them long after their balloon has gone. Patients benefit from six months of dietary support from a nutritionist to ensure lasting lifestyle changes alongside an Allurion body composition scale, health tracker watch and mobile app, and the company hopes that their program can help anyone who has excess weight to lose without them having to constantly feel hungry.

Further information and interview requests
kim@blackandwhitecomms.com / sophie@blackandwhitecomms.com

Allurion

Allurion's Elipse Program is the world's first and only weight loss device that requires no surgery, endoscopy* or anaesthesia. A swallowable capsule that expands in the stomach to around the size of a grapefruit and allows patients to lose an average of 10 to 15% after approximately 16 weeks.

*In rare cases Elipse Balloon may require endoscopic or surgical intervention for removal.

www.allurion.com

@alluriontech

Honey Langcaster-James:

A well-known Consultant Psychologist, Psychotherapist and broadcaster. Founder and Director of Services of global media psychology consultancy On Set Welfare, a Fellow of Healthcare Improvement Leadership at Imperial College London and consultant to global organisations, including the UK Government.

© 2021 PR Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.